Anticoagulation in Continuous Renal Replacement Procedures
- 1 January 1992
- journal article
- Published by Wiley in Seminars in Dialysis
- Vol. 5 (1) , 61-68
- https://doi.org/10.1111/j.1525-139x.1992.tb00458.x
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patientsKidney International, 1990
- CONTINUOUS ARTERIOVENOUS HAEMODIALYSIS IN CRITICALLY ILL PATIENTSThe Lancet, 1988
- Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltrationKidney International, 1988
- Anticoagulation for Continuous Arteriovenous Hemofiltration in ChildrenBlood Purification, 1988
- Solute transport in continuous hemodialysis: A new treatment for acute renal failureKidney International, 1987
- Hemodialysis using gabexate mesilate (FOY) in patients with a high bleeding riskCritical Care Medicine, 1986
- Continuous Arteriovenous Hemofiltration with Low-Molecular-Weight HeparinNephron, 1985
- Regional Citrate Anticoagulation for Hemodialysis in the Patient at High Risk for BleedingNew England Journal of Medicine, 1983
- Prostacyclin as the Sole Antithrombotic Agent for Acute Renal Failure HemodialysisNephron, 1983
- Hemodialysis Using Prostacyclin Instead of Heparin as the Sole Antithrombotic AgentNew England Journal of Medicine, 1981